Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06653452
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-20
Brief Title:
Application of PETMRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Application of PETMRI in the Evaluation of the Efficacy of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study plans to include LARC patients receiving neoadjuvant therapy at this center conducting PETCT and PETMR examinations before treatment and PETMR examinations before surgery after neoadjuvant therapy The changes in the lesion before and after treatment will be compared to evaluate the efficacy of neoadjuvant therapy including the relief situation of the rectal primary lesion lymph node metastasis local infiltration around the tumor peritoneal and other distant metastases etc The pathological relief diagnosed by surgical pathology is the gold standard and the predictive efficacy of PETMR will be evaluated comparing the advantages and disadvantages of 18F-FDG and 68Ga-FAPI PETMR and comparing with traditional PETCT and rectal MRI to explore the value of PETMRI in predicting the efficacy of neoadjuvant therapy in LARC patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None